Richard P. Batycky
Independent DirectorDr. Richard P. Batycky, also known as Rick, Ph.D., has been Independent Director of Pulmatrix, Inc. since November 2019. He is Chief Executive Officer of Nocion Therapeutics, Inc. since August 2018 and serves as its President since 2020 and Serves as its Director. Dr. Batycky has experience in drug development across an array of platforms and disease states and has been with several start-ups from founding through acquisition. He Co-Founded of Civitas Therapeutics, Inc. in 2009 and served as its Chief Scientific Officer since December 2010 until 2014. Dr. Batycky served as the Chief Technology Officer and Site Head of Acorda Therapeutics, Inc. from October 2014 to August 20, 2018. Dr. Batycky served as Chief Scientific Officer and Senior Vice President of Research & Development at Pulmatrix, Inc. from 2007 to 2009. Prior to joining Pulmatrix, Dr. Batycky was Vice President of Research and Development for Alkermes, Inc. and oversaw many facets of product development across pulmonary, injectable and oral platforms. He was involved in the development of over 10 product candidates (both proprietary and partnered) across multiple delivery platforms (pulmonary, injectable and oral) in various stages. He held prior positions at Alkermes and Advanced Inhalation Research from 1998 to 2007. Dr. Batycky was an original member of Advanced Inhalation Research (AIR®), where he oversaw product development utilizing the ARCUS® technology for pulmonary delivery. Prior to AIR®, Dr. Batycky was an Assistant Professor of Chemical Engineering at the University of Alberta and a post-doctoral fellow at Pennsylvania State University. Dr. Batycky received his B.Sc. in Chemical Engineering from University of Calgary and his S.M. and Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology (MIT).
Positions
- Company NamePulmatrix, Inc.Stock CodePULMPositionIndependent Director
